All the Credit, Ep. 47 - Holiday Indigestion: The Investment Implications of GLP-1s

In recent months, GLP-1 drugs have been thrust into the spotlight, amplified by increased media attention and several headline-grabbing comments from large retailers. In this episode of All the Credit®, host Brian Barnhurst, CFA, Co-Head of Credit Research, is joined by U.S. Leveraged Finance Credit Research Analysts, Elizabeth Halpin, CFA, Richard Kus, CFA, and Scott Swanson, CFA, to consider the investment implications of GLP-1s across fixed income markets and industries.

Recorded on December 19, 2023.

THIS CONTENT IS INVESTMENT FOCUSED AND NOT INTENDED TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL OR HEALTH ADVICE, DIAGNOSIS, OR TREATMENT, AND DOES NOT CONSTITUTE MEDICAL OR OTHER PROFESSIONAL ADVICE IN ANY FORM.

Listen Here